Owens & Minor (NYSE:OMI) Reaches New 52-Week Low – Should You Sell?

Owens & Minor, Inc. (NYSE:OMI)’s share price reached a new 52-week low on Tuesday . The stock traded as low as $7.24 and last traded at $7.23, with a volume of 91602 shares traded. The stock had previously closed at $7.45.

Wall Street Analyst Weigh In

OMI has been the topic of a number of analyst reports. Citigroup decreased their price objective on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research report on Tuesday, November 5th. UBS Group decreased their price objective on shares of Owens & Minor from $25.00 to $13.00 and set a “buy” rating on the stock in a research report on Thursday, February 13th. Barclays decreased their price objective on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 5th. Finally, Robert W. Baird reduced their price target on shares of Owens & Minor from $15.00 to $14.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 4th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $16.79.

Owens & Minor Price Performance

The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45. The firm’s 50 day moving average is $12.53 and its 200 day moving average is $13.69. The firm has a market cap of $543.39 million, a P/E ratio of -10.84, a price-to-earnings-growth ratio of 0.25 and a beta of 0.48.

Insider Buying and Selling

In other news, CFO Jonathan A. Leon sold 5,282 shares of the company’s stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $11.82, for a total value of $62,433.24. Following the transaction, the chief financial officer now owns 130,822 shares in the company, valued at approximately $1,546,316.04. This represents a 3.88 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. 3.59% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Owens & Minor by 29.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 219,761 shares of the company’s stock valued at $2,872,000 after purchasing an additional 50,184 shares during the period. Voloridge Investment Management LLC lifted its position in Owens & Minor by 24.2% during the fourth quarter. Voloridge Investment Management LLC now owns 243,525 shares of the company’s stock valued at $3,183,000 after purchasing an additional 47,459 shares during the period. Squarepoint Ops LLC bought a new position in Owens & Minor during the fourth quarter valued at approximately $381,000. State of Wyoming lifted its position in Owens & Minor by 35.3% during the fourth quarter. State of Wyoming now owns 23,198 shares of the company’s stock valued at $303,000 after purchasing an additional 6,050 shares during the period. Finally, ProShare Advisors LLC lifted its position in Owens & Minor by 44.5% during the fourth quarter. ProShare Advisors LLC now owns 22,702 shares of the company’s stock valued at $297,000 after purchasing an additional 6,996 shares during the period. Institutional investors own 98.04% of the company’s stock.

About Owens & Minor

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.